|Enhanced detection of circulating tumor DNA by fragment size analysis|
F Mouliere, D Chandrananda, AM Piskorz, EK Moore, J Morris, ...
Science translational medicine 10 (466), eaat4921, 2018
|High-resolution characterization of sequence signatures due to non-random cleavage of cell-free DNA|
D Chandrananda, NP Thorne, M Bahlo
BMC medical genomics 8 (1), 29, 2015
|Association of plasma and urinary mutant DNA with clinical outcomes in muscle invasive bladder cancer|
KM Patel, KE Van Der Vos, CG Smith, F Mouliere, D Tsui, J Morris, ...
Scientific reports 7 (1), 1-12, 2017
|Detection of cell‐free DNA fragmentation and copy number alterations in cerebrospinal fluid from glioma patients|
F Mouliere, R Mair, D Chandrananda, F Marass, CG Smith, J Su, J Morris, ...
EMBO molecular medicine 10 (12), 2018
|Use of copy number deletion polymorphisms to assess DNA chimerism|
DL Bruno, D Ganesamoorthy, NP Thorne, L Ling, M Bahlo, S Forrest, ...
Clinical chemistry 60 (8), 1105-1114, 2014
|Investigating and correcting plasma DNA sequencing coverage bias to enhance aneuploidy discovery|
D Chandrananda, NP Thorne, D Ganesamoorthy, DL Bruno, Y Benjamini, ...
PLoS One 9 (1), 2014
|Effects of collection and processing procedures on plasma circulating cell-free DNA from cancer patients|
B Risberg, DWY Tsui, H Biggs, ARVM de Almagro, SJ Dawson, ...
The Journal of Molecular Diagnostics 20 (6), 883-892, 2018
|Dynamics of multiple resistance mechanisms in plasma DNA during EGFR‐targeted therapies in non‐small cell lung cancer|
DWY Tsui, M Murtaza, ASC Wong, OM Rueda, CG Smith, ...
EMBO molecular medicine 10 (6), 2018
|Measurement of plasma cell-free mitochondrial tumor DNA improves detection of glioblastoma in patient-derived orthotopic xenograft models|
R Mair, F Mouliere, CG Smith, D Chandrananda, D Gale, F Marass, ...
Cancer research 79 (1), 220-230, 2019
|Selecting short DNA fragments in plasma improves detection of circulating tumour DNA|
F Mouliere, AM Piskorz, D Chandrananda, E Moore, J Morris, CG Smith, ...
BioRxiv, 134437, 2017
|MA 11.02 circulating tumor DNA in early stage NSCLC: High sensitivity analysis in low burden disease. LUCID study update|
A Ruiz-Valdepenas, K Heider, G Doughton, W Qian, C Massie, ...
Journal of Thoracic Oncology 12 (11), S1843-S1844, 2017
|Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors|
CG Smith, T Moser, F Mouliere, J Field-Rayner, M Eldridge, AL Riediger, ...
Genome medicine 12 (1), 1-17, 2020
|High-sensitivity monitoring of ctDNA by patient-specific sequencing panels and integration of variant reads|
JCM Wan, K Heider, D Gale, S Murphy, E Fisher, J Morris, F Mouliere, ...
bioRxiv, 759399, 2019
|Circulating tumour DNA as a diagnostic biomarker in high-grade serous ovarian cancer|
E Moore, T Goranova, H Addley, A Piskorz, F Mouliere, D Chandrananda, ...
Bjog-an International Journal of Obstetrics and Gynaecology 125 (8), E30-E30, 2018
|Individualised monitoring of patients with metastatic melanoma using plasma DNA|
J Wan, S Murphy, D Gale, J Morris, FC Mouliere, F Marass, K Heider, ...
The Lancet 389, S99, 2017
|Integrated clonal analysis reveals circulating tumor DNA in urine and plasma of glioma patients|
F Mouliere, K Heider, CG Smith, J Su, M Thompson, J Morris, JCM Wan, ...
bioRxiv, 758441, 2019
|Effects of Collection and Processing Procedures on Plasma Circulating Cell-Free DNA from Cancer Patients|
C Hodgkin, L Jones, C Parkinson, A Piskorz, F Marass, D Chandrananda, ...
|PO-483 Improved sensitivity for non-invasive diagnosis of high-grade serous ovarian cancer|
E Moore, D Chandrananda, A Piskorz, F Mouliere, T Goranova, H Addley, ...
ESMO Open 3 (Suppl 2), A419-A419, 2018
|Analysis of whole-genome sequencing data from cell-free DNA in maternal plasma to detect fetal aneuploidy|
|Contributed paper–Dineika Chandrananda and Chris Wild A FREE STAND-ALONE SYSTEM FOR STATISTICAL DATA ANALYSIS WRITTEN IN R|
OZCOTS 2010, 44, 2010